Leith Wheeler Investment Counsel Ltd. Has $32.37 Million Holdings in Humana Inc. (NYSE:HUM)

Leith Wheeler Investment Counsel Ltd. boosted its holdings in shares of Humana Inc. (NYSE:HUM) by 1.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 127,592 shares of the insurance provider’s stock after purchasing an additional 2,390 shares during the period. Humana accounts for approximately 2.3% of Leith Wheeler Investment Counsel Ltd.’s holdings, making the stock its 12th largest holding. Leith Wheeler Investment Counsel Ltd.’s holdings in Humana were worth $32,371,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the business. Transcend Capital Advisors LLC raised its holdings in shares of Humana by 399.7% in the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider’s stock valued at $924,000 after buying an additional 2,914 shares during the last quarter. FNY Investment Advisers LLC lifted its position in shares of Humana by 6,647.5% during the fourth quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock worth $6,916,000 after purchasing an additional 26,856 shares in the last quarter. Retirement Systems of Alabama grew its stake in shares of Humana by 735.9% during the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock valued at $55,563,000 after purchasing an additional 192,801 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in shares of Humana by 7.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider’s stock valued at $244,811,000 after purchasing an additional 65,735 shares in the last quarter. Finally, Secure Asset Management LLC bought a new position in Humana in the 4th quarter worth approximately $244,000. Institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have commented on the company. Morgan Stanley decreased their price objective on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 12th. Mizuho lifted their price objective on Humana from $305.00 to $316.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 9th. Barclays boosted their price objective on Humana from $270.00 to $322.00 and gave the stock an “equal weight” rating in a report on Friday, April 11th. Guggenheim assumed coverage on shares of Humana in a research note on Wednesday, April 9th. They issued a “buy” rating and a $326.00 target price on the stock. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $283.00 price target on shares of Humana in a research note on Wednesday, February 12th. Seventeen investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $284.90.

Humana Trading Down 0.5 %

NYSE HUM opened at $263.08 on Tuesday. Humana Inc. has a one year low of $213.31 and a one year high of $406.46. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The firm has a market cap of $31.75 billion, a P/E ratio of 26.44, a P/E/G ratio of 2.05 and a beta of 0.62. The stock’s 50-day moving average is $266.31 and its 200-day moving average is $270.84.

Humana (NYSE:HUM) last announced its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Sell-side analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.35%. The ex-dividend date of this dividend is Friday, June 27th. Humana’s payout ratio is presently 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.